Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benazepril plus hydrochlorothiazide in essential hypertension
NCT00367094Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hydrochlorothiazide in essential hypertension (2 arms), sponsored by Novartis. Primary endpoint: Change in diastolic blood pressure from baseline to week 8. Started Jul 2006; status: completed.
02
Drugs
hydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00367094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367094.